GlobalData on MSN
Genespire to take rare disease gene therapy to clinic in 2026
GENE202 is a single dose gene therapy for patients with rare metabolic disease, methylmalonic acidaemia.
Iain Cheeseman and colleagues reveal the underappreciated role of single genes producing multiple proteins in atypical presentations of rare disease, and present case studies of affected patients ...
News-Medical.Net on MSN
Gene therapy targeting connexin 43 shows promise across inherited heart diseases
University of California San Diego-led team has discovered that restoring a key cardiac protein called connexin‑43 in a mouse ...
MedPage Today on MSN
Alzheimer's risk may be driven by a single gene
APOE's contribution to disease burden has been "long underestimated," researcher ...
No gene acts alone: interacting variants and protein partnerships can worsen, mask or even rescue disease risk, demanding ...
Many genetic variants linked to inherited eye disorders rarely lead to disease, meaning up to 2% of people could carry these variants without ever developing vision problems, according to a new s tudy ...
Genetic research is finally starting to explain how DNA risk scores translate into real disease, not just in single genes but across entire biological networks. Instead of treating each variant as an ...
14don MSN
Mapping gene disruptions in sporadic early onset Alzheimer's disease across key brain regions
A new study led by researchers at UTHealth Houston investigated both gene expression and regulation at single cell levels to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results